Literature DB >> 15828049

Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine.

Marie Stiborová1, Markéta Miksanová, Miroslav Sulc, Helena Rýdlová, Heinz H Schmeiser, Eva Frei.   

Abstract

2-methoxyaniline (o-anisidine) is an industrial and environmental pollutant and a bladder carcinogen for rodents. The mechanism of its carcinogenicity was investigated with 2 independent methods, 32P-postlabeling and 14C-labeled o-anisidine, to show that o-anisidine binds covalently to DNA in vitro after its activation by human hepatic microsomes. We also investigated the capacity of o-anisidine to form DNA adducts in vivo. Rats were treated i.p. with o-anisidine (0.15 mg/kg daily for 5 days) and DNA from several organs was analyzed by 32P-postlabeling. Two o-anisidine-DNA adducts, identical to those found in DNA incubated with o-anisidine and human microsomes in vitro, were detected in urinary bladder (4.1 adducts per 10(7) nucleotides), the target organ, and, to a lesser extent, in liver, kidney and spleen. These DNA adducts were identified as deoxyguanosine adducts derived from a metabolite of o-anisidine, N-(2-methoxyphenyl)hydroxylamine. This metabolite was identified in incubations with human microsomes. With 9 human hepatic microsomal preparations, we identified the specific CYP catalyzing the formation of the o-anisidine metabolites by correlation studies and by examining the effects of CYP inhibitors. On the basis of these analyses, oxidation of o-anisidine was attributed mainly to CYP2E1. Using recombinant human CYP (in Supersomes) and purified CYPs, the participation of CYP2E1 in o-anisidine oxidation was confirmed. In Supersomes, CYP1A2 was even more efficient in oxidizing o-anisidine than CYP2E1, followed by CYP2B6, 1A1, 2A6, 2D6 and 3A4. The results, the first report on the potential of the human microsomal CYP enzymes to activate o-anisidine, strongly suggest a carcinogenic potential of this rodent carcinogen for humans. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828049     DOI: 10.1002/ijc.21122

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Evaluating Metabolite-Related DNA Oxidation and Adduct Damage from Aryl Amines Using a Microfluidic ECL Array.

Authors:  Itti Bist; Snehasis Bhakta; Di Jiang; Tia E Keyes; Aaron Martin; Robert J Forster; James F Rusling
Journal:  Anal Chem       Date:  2017-11-09       Impact factor: 6.986

3.  Cytochrome P450-mediated metabolism of N-(2-methoxyphenyl)-hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole.

Authors:  Karel Naiman; Helena Dračínská; Martin Dračínský; Markéta Martínková; Václav Martínek; Petr Hodek; Martin Stícha; Eva Frei; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2008-12

4.  Genotoxic mechanisms for the carcinogenicity of the environmental pollutants and carcinogens o-anisidine and 2-nitroanisole follow from adducts generated by their metabolite N-(2-methoxyphenyl)-hydroxylamine with deoxyguanosine in DNA.

Authors:  Marie Stiborová; Karel Naiman; Markéta Martínková; Václav Martínek; Martina Svobodová; Heinz H Schmeiser; Eva Frei
Journal:  Interdiscip Toxicol       Date:  2009-03

5.  Comet assay evaluation of six chemicals of known genotoxic potential in rats.

Authors:  Cheryl A Hobbs; Leslie Recio; Michael Streicker; Molly H Boyle; Jin Tanaka; Atsushi Shiga; Kristine L Witt
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-07       Impact factor: 2.873

6.  Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling.

Authors:  Marie Stiborova
Journal:  J Vis Exp       Date:  2018-03-20       Impact factor: 1.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.